RecruitingOsteoarthritis · Overweight and Obesity
Study for People With Excess Body Weight and Knee Osteoarthritis
Montreal, Quebec
Bronchiectasis is a long-term condition in which the airways in your lungs become permanently widened and scarred, usually after infection or inflammation has damaged their walls. Damaged airways cannot clear mucus properly, so it collects, bacteria settle in it, and chest infections keep coming back. Day to day it often means a daily cough that brings up phlegm, tiredness that is hard to explain to other people, and several courses of antibiotics a year.
Bronchiectasis is often mistaken for COPD or asthma, and people are sometimes treated for those for years first. The difference is structural. In COPD the airways are narrowed and the small air sacs are damaged, usually after long-term exposure such as smoking. In bronchiectasis the airways themselves have been stretched wide and scarred, which is why mucus pools and infections return. Some people live with more than one of these conditions at once, and that is part of why a CT scan is used when repeated infections do not fit a straightforward picture.
It is also not a single disease with a single cause. Bronchiectasis is the end result of many different processes, including past severe infections, inherited conditions, immune deficiencies and autoimmune disease. Finding the underlying cause is not an academic exercise: Canadian guidance in CMAJ notes that identifying it changes management in as many as 37 percent of adults.
Symptoms differ a great deal between people and often run in a cycle: a stable stretch, then a flare-up with more phlegm and less energy, then a slow recovery.

Some things cannot be changed:
Others can often be worked on, usually with support from a health care team:
Bronchiectasis is confirmed with a high-resolution CT scan of the chest, which shows airways that are wider than the blood vessel beside them and airway walls that are thickened. Canadian guidance in CMAJ notes the scan is ideally done when you are clinically stable rather than in the middle of a flare-up. Once bronchiectasis is confirmed, further tests look for a cause and guide care: spirometry and other lung function tests, sputum cultures for bacteria and for nontuberculous mycobacteria, blood tests of immune function, and sweat chloride or genetic testing for cystic fibrosis where that is relevant.
Clinical research for Bronchiectasis is enrolling. See the current studies
Care for bronchiectasis is built around clearing mucus, treating and spacing out infections, and dealing with whatever is driving the damage. Depending on your scan, your sputum results and how often you have flare-ups, a health care team may discuss:
Because the causes differ so much, two people with bronchiectasis can end up with quite different plans. These are decisions for you and your own clinician, and this page is not a recommendation about any of them.
There is no approved medicine in Canada specifically for bronchiectasis, so care is largely borrowed from cystic fibrosis and COPD practice. Clinicians cannot yet predict who will deteriorate, or which people gain from long-term antibiotics. Canada also lacks basic figures on how many people are affected, which is why the Canadian Bronchiectasis and NTM Registry was set up and linked with the European EMBARC and United States registries. Studies now underway in Canada and internationally include neutrophil serine protease inhibitors such as DPP-1 inhibitors, inhaled antibiotic formulations, new regimens for nontuberculous mycobacterial lung disease, and airway clearance and rehabilitation strategies.
Registries and trials are different things, and joining one does not commit you to the other. Both are voluntary, both begin with informed consent, and you can withdraw at any time without affecting the care you get from your own team. No one can say in advance whether a study will help you personally.
This page is written in plain language for people considering clinical research. It is general health information, not medical advice, and it does not replace a conversation with your own doctor or nurse practitioner.
No. COPD is usually caused by long-term exposure such as smoking and involves narrowed airways and damaged air sacs. Bronchiectasis involves airways that have become permanently widened and scarred, so mucus builds up and infections keep returning. Some people have both conditions at once, which is why a CT scan is used when repeated infections do not fit a straightforward COPD picture.
Sputum cultures show which bacteria are living in your airways, including organisms such as Pseudomonas aeruginosa and nontuberculous mycobacteria. Knowing what is there guides which antibiotics your clinician chooses during a flare-up and whether specialised treatment is needed. Cultures are usually repeated over time because the organisms can change.
Canada does not have national figures on how many people live with bronchiectasis, which makes it hard to plan services or run trials. The Canadian Bronchiectasis and NTM Registry collects clinical and quality of life information from participating clinics and connects with registries in Europe and the United States. Joining a registry is voluntary and is separate from deciding to take part in a treatment trial.
RecruitingOsteoarthritis · Overweight and Obesity
Montreal, Quebec
Recruiting
RecruitingOsteoarthritis · Overweight and Obesity
Toronto & Stouffville, Ontario
RecruitingType 2 Diabetes · Overweight and Obesity
Sarnia & Hamilton, Ontario
Recruiting
Recruiting